GRIFOLS, S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.81 EUR | -2.85% |
|
+5.75% | -35.45% |
| 05-17 | European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading | MT |
| 05-15 | GRIFOLS : In line Q1 and on track deleveraging; worth a go |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 90.45B | ||||||
| 41.45B | ||||||
| 33.57B | ||||||
| 25.73B | ||||||
| 14.73B |
